On another blog, at the end of the summer, I spent far too much space trying to figure out what we should think about Lance Armstrong after his quasi-implicit-wink’n'nudge-pseudo-confession. That statement from Armstrong came as he announced his decision to, in essence, plead “no contest” to the US Anti-Doping Agency’s public hearing of his case. My colleague Chris MacDonald follows up on the case on his Business Ethics Blog — and does so much more concisely, and with special attention to the “adversarial ethics” angle.
On Wednesday (October 10), the United States Anti-Doping Agency (USADA) released a small mountain’s worth of evidence against champion cyclist Lance Armstrong. Not surprisingly, comparisons to corruption in the world of business were not far behind. On Twitter, a number of wags referred to Armstrong as the “Bernie Madoff of cycling,” or variants on that.
The comparison with Madoff is to be expected. In both cases, you have wrongdoing of impressive scope. In both cases, the wrongdoing was truly brazen, going on right under the noses of regulators. In both cases, you can’t escape the feeling that someone should have been able to figure it all out sooner. And in both cases, you see the eventual fall of a man who was a hero to many.
But the comparison is also off target in important ways….